Drug that prevents hot flushes to be available on NHS in England

Veoza, also known as fezolinetant, will be offered to women for whom HRT is unsuitable

More than 500,000 women in England are to be offered a drug on the NHS that prevents hot flushes.

The green light for Veoza, also known as fezolinetant, comes after the medicines watchdog, the National Institute for Health and Care Excellence, authorised it for use on Wednesday.